Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

International cohort study of 73 anti-Ku-positive patients: association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis.

Lakota K, Thallinger GG, Sodin-Semrl S, Rozman B, Ambrozic A, Tomsic M, Praprotnik S, Cucnik S, Mrak-Poljsak K, Ceribelli A, Cavazzana I, Franceschini F, Vencovsky J, Czirják L, Varjú C, Steiner G, Aringer M, Stamenkovic B, Distler O, Matucci-Cerinic M, Kveder T.

Arthritis Res Ther. 2012 Jan 6;14(1):R2. doi: 10.1186/ar3550.

2.

Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients.

Franceschini F, Cavazzana I, Generali D, Quinzanini M, Viardi L, Ghirardello A, Doria A, Cattaneo R.

J Rheumatol. 2002 Jul;29(7):1393-7.

PMID:
12136894
3.

Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case-control study.

Rozman B, Cucnik S, Sodin-Semrl S, Czirják L, Varjú C, Distler O, Huscher D, Aringer M, Steiner G, Matucci-Cerinic M, Guiducci S, Stamenkovic B, Stankovic A, Kveder T.

Ann Rheum Dis. 2008 Sep;67(9):1282-6. Epub 2007 Dec 6.

PMID:
18063672
4.

Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases.

Cavazzana I, Ceribelli A, Quinzanini M, Scarsi M, Airò P, Cattaneo R, Franceschini F.

Lupus. 2008 Aug;17(8):727-32. doi: 10.1177/0961203308089442.

PMID:
18625650
5.

Anti-Ku autoantibodies: series of 5 cases.

Gryga K, Milewski M, Zółciński M, Dyczek A, Musiał J.

Pol Arch Med Wewn. 2009 Jan-Feb;119(1-2):95-7.

6.

A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies.

Cavazzana I, Fredi M, Taraborelli M, Quinzanini M, Tincani A, Franceschini F.

Clin Exp Rheumatol. 2013 Mar-Apr;31(2 Suppl 76):118-21. Epub 2013 Jul 23.

PMID:
23910615
7.

Antibodies against Ku protein in sera from patients with autoimmune diseases.

Yaneva M, Arnett FC.

Clin Exp Immunol. 1989 Jun;76(3):366-72.

8.

Clinical and serological associations of autoantibodies to the Ku70/Ku80 heterodimer determined by a novel chemiluminescent immunoassay.

Mahler M, Swart A, Wu J, Szmyrka-Kaczmarek M, Senécal JL, Troyanov Y, Hanly JG, Fritzler MJ.

Lupus. 2016 Jul;25(8):889-96. doi: 10.1177/0961203316640918.

PMID:
27252266
9.

Role of antigen selectivity in autoimmune responses to the Ku (p70/p80) antigen.

Reeves WH, Sthoeger ZM, Lahita RG.

J Clin Invest. 1989 Aug;84(2):562-7.

10.
11.
12.

Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD).

Bodolay E, Csiki Z, Szekanecz Z, Ben T, Kiss E, Zeher M, Szücs G, Dankó K, Szegedi G.

Clin Exp Rheumatol. 2003 May-Jun;21(3):313-20.

PMID:
12846049
13.

A prospective analysis of anti-desmoglein antibody profiles in patients with rheumatoid arthritis treated with thiol compounds.

Yamamoto T, Takata-Michigami M, Hisamatsu Y, Yamamoto T, Hamada T, Fujii K, Fujimoto W, Taneichi K, Aoyama Y, Iwatsuki K.

J Dermatol Sci. 2010 Sep;59(3):170-5. doi: 10.1016/j.jdermsci.2010.06.007. Epub 2010 Jun 30.

PMID:
20650613
14.

Human autoantibodies stabilize the quaternary structure of Ku antigen.

Wang J, Dong X, Stojanov L, Kimpel D, Satoh M, Reeves WH.

Arthritis Rheum. 1997 Jul;40(7):1344-53.

PMID:
9214436
16.

Clinical performance evaluation of a novel rapid response chemiluminescent immunoassay for the detection of autoantibodies to extractable nuclear antigens.

Bentow C, Swart A, Wu J, Seaman A, Manfredi M, Infantino M, Benucci M, Lakos G, Mahler M.

Clin Chim Acta. 2013 Sep 23;424:141-7. doi: 10.1016/j.cca.2013.05.011. Epub 2013 May 30.

17.

Antibodies to the p70/p80 (Ku) antigens in systemic lupus erythematosus.

Reeves WH.

Rheum Dis Clin North Am. 1992 May;18(2):391-414. Review.

PMID:
1626075
18.

Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.

Damoiseaux J, Boesten K, Giesen J, Austen J, Tervaert JW.

Ann N Y Acad Sci. 2005 Jun;1050:340-7.

PMID:
16014550
19.

Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis.

Patterson KA, Roberts-Thomson PJ, Lester S, Tan JA, Hakendorf P, Rischmueller M, Zochling J, Sahhar J, Nash P, Roddy J, Hill C, Nikpour M, Stevens W, Proudman SM, Walker JG.

Arthritis Rheumatol. 2015 Dec;67(12):3234-44. doi: 10.1002/art.39316.

20.

Inflammatory myopathies with anti-Ku antibodies: a prognosis dependent on associated lung disease.

Rigolet A, Musset L, Dubourg O, Maisonobe T, Grenier P, Charuel JL, Behin A, Herson S, Amoura Z, Benveniste O.

Medicine (Baltimore). 2012 Mar;91(2):95-102. doi: 10.1097/MD.0b013e31824d9cec.

Supplemental Content

Support Center